Gazyva (obinutuzumab) in India

 

Medical Evidence gazyvaro

Generic name : Obinutuzumab.

Trade name : Gazyva.

Manufacturer information :

Gazyva is manufactured by Genentech, Inc.

Gazyva FDA Approval :

Gazyva first approved November 1st, 2013.

Gazyva Dosage form :

1000 mg/40 mL (25 mg/mL) single-use vial.

Gazyva Indications and Usage :

Chronic Lymphocytic Leukemia

Indicated for previously untreated chronic lymphocytic leukemia in combination with chlorambucil.

Gazyva (Obinutuzumab) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.